Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Hypoxia-Associated Long Non-Coding RNAs in Breast Cancer. | Cells | 2022 | 35626715 | PubTator, text mining | PubMed |
| The Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis. | Biomolecules | 2022 | 35625561 | PubTator, text mining | PubMed |
| Prospective Application of Ferroptosis in Hypoxic Cells for Tumor Radiotherapy. | Antioxidants (Basel) | 2022 | 35624785 | PubTator, text mining | PubMed |
| Oxygen level regulates N-terminal translation elongation of selected proteins through deoxyhypusine hydroxylation. | Cell Rep | 2022 | 35613595 | PubTator, text mining | PubMed |
| Regulation of Transactivation at C-TAD Domain of HIF-1α by Factor-Inhibiting HIF-1α (FIH-1): A Potential Target for Therapeutic Intervention in Cancer. | Oxid Med Cell Longev | 2022 | 35592530 | PubTator, text mining | PubMed |
| Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells. | Blood Adv | 2022 | 35580333 | PubTator, text mining | PubMed |
| Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer. | Front Oncol | 2022 | 35574342 | PubTator, text mining | PubMed |
| Management of Pheochromocytomas and Paragangliomas: A Case-Based Review of Clinical Aspects and Perspectives. | J Clin Med | 2022 | 35566714 | PubTator, text mining | PubMed |
| Hypoxia as a Modulator of Inflammation and Immune Response in Cancer. | Cancers (Basel) | 2022 | 35565420 | PubTator, text mining | PubMed |
| Friend or Foe: The Relativity of (Anti)oxidative Agents and Pathways. | Int J Mol Sci | 2022 | 35563576 | PubTator, text mining | PubMed |
| Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling. | Int J Mol Sci | 2022 | 35563538 | PubTator, text mining | PubMed |
| Modulating Nucleus Oxygen Concentration by Altering Intramembrane Cholesterol Levels: Creating Hypoxic Nucleus in Oxic Conditions. | Int J Mol Sci | 2022 | 35563465 | PubTator, text mining | PubMed |
| Construction of a hypoxia-immune-related prognostic model and targeted therapeutic strategies for cervical cancer. | Int Immunol | 2022 | 35561666 | PubTator, text mining | PubMed |
| Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension. | Sci Rep | 2022 | 35551212 | PubTator, text mining | PubMed |
| Immune cells-derived exosomes function as a double-edged sword: role in disease progression and their therapeutic applications. | Biomark Res | 2022 | 35550636 | PubTator, text mining | PubMed |
| AMP-activated protein kinase α1 phosphorylates PHD2 to maintain systemic iron homeostasis. | Clin Transl Med | 2022 | 35538889 | PubTator, text mining | PubMed |
| Hypoxia-Reoxygenation Couples 3βHSD1 Enzyme and Cofactor Upregulation to Facilitate Androgen Biosynthesis and Hormone Therapy Resistance in Prostate Cancer. | Cancer Res | 2022 | 35536859 | PubTator, text mining | PubMed |
| Role of abnormal energy metabolism in the progression of chronic kidney disease and drug intervention. | Ren Fail | 2022 | 35535500 | PubTator, text mining | PubMed |
| Migration and descent, adaptations to altitude and tuberculosis in Nepalis and Tibetans. | Evol Med Public Health | 2022 | 35528702 | PubTator, text mining | PubMed |
| EGLN1 induces tumorigenesis and radioresistance in nasopharyngeal carcinoma by promoting ubiquitination of p53 in a hydroxylase-dependent manner. | J Cancer | 2022 | 35517429 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers?page=44